AzTrials
AzTrials

Temporomandibular DisorderNCT05318313

Telerehabilitation for TMD

An observational study of Temporomandibular Disorder and TMJ Disc Displacement With Reduction, run by University of Minnesota at 1 site in United States.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

This study will compare after physical therapy for Temporomandibular Disorders (TMD) performed either in-person or virtually using telerehabilitation. Comparing diagnostic reliability and quality-of-life outcomes in each group will determine (based on a 10% margin) whether delivering physical therapy via… Read more about this study

Who is it for?
Ages 18 to 70 years
What is being tested?
Telerehabilitation
How many people
207 participants
Where
1 siteUnited States
Study dates
17 Jun 2022to 1 Jul 2024
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 70 years
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Study population: Individuals diagnosed with at least one subtype of temporomandibular disorders by a TMD specialist at the University of Minnesota TMD, Orofacial Pain and Dental Sleep Medicine Clinic and referred for physical therapy at the same clinic.

Who may be able to join

  • 18-70 years old
  • Referred to PT with ≥1 TMD subtype diagnosis
  • PI has no previous knowledge of the participant's diagnosis
  • Email access
  • Possession of any device that can be positioned for hands-free TR visits (TR group only)
  • Willingness and ability to comply with all study requirements and PT program
  • Able to provide informed consent

Who cannot join

  • Non-English speakers
  • Permanent residence outside of the state of Minnesota (TR group only)
  • Women in the last trimester of pregnancy
  • Referred for post-surgical rehabilitation
  • Severe chronic pain as identified by level 4 classification on the GCPS
  • Current diagnosis or existence of the following conditions that can limit response to PT and participation in study activities:
Show all 13Show fewer
  • Neuropathic pain
  • Fibromyalgia and/or generalized widespread pain on both sides of the body in ≥3 areas above and below the waist
  • Rheumatoid arthritis or juvenile idiopathic arthritis
  • Dystonia or other movement disorder
  • Fractures and/or recent jaw or facial trauma
  • Malignancies
  • Current substance abuse

Trial locations and contacts

1 site in 1 country.

United States1 site
  • University of Minnesota

    Minneapolis, Minnesota, 55455

Other trials in United States

About this study

Official title: Telerehabilitation Effectiveness for Individuals With Temporomandibular Disorders (TMD): A Non-Inferiority Study

This study will compare after physical therapy for Temporomandibular Disorders (TMD) performed either in-person or virtually using telerehabilitation. Comparing diagnostic reliability and quality-of-life outcomes in each group will determine (based on a 10% margin) whether delivering physical therapy via telerehabilitation is as good as standard in-person care for these individuals. Long term outcomes including patient satisfaction, cost-effectiveness analysis, and functional status will describe the feasibility of telerehabilitation as a management intervention for this population.

Being tested
Telerehabilitation
Keywords
Temporomandibular Disorders, TMD, telerehabilitation, telehealth, physical therapy, PT
Medical subject headings
Temporomandibular Joint Disorders

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • TelerehabilitationOther

    The TR PT evaluation and follow-up visits will be performed via Zoom software

Study groups in NCT05318313
Study groupRoleWhat they receive
Telerehabilitation onlyParticipants choose to have all of their physical therapy provided virtually throughout the length of the study
Receives: Other: Telerehabilitation
In-person onlyParticipants choose to have all of their physical therapy provided in-person throughout the length of the study
Hybrid 1The TR PT evaluation and follow-up visits in the initial 6 weeks will be performed via Zoom software and subsequent follow-up visits will switch to in person after 6 weeks
Receives: Other: Telerehabilitation
Hybrid 2The PT evaluation and follow-up visits in the initial 6 weeks will be performed in person and will switch to TR via Zoom software after 6 weeks
Receives: Other: Telerehabilitation

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Specialist diagnosis

    Diagnosis will be determined by putting clinical assessment results into the Brief Diagnostic Criteria for TMD (Brief DC/TMD) algorithm and getting one or more of 7 possible diagnoses: TMJ arthralgia (joint), Masticatory myofascial pain (muscle), TMJ disc displacement with reduction (joint), TMJ disc displacement without reduction (joint), TMJ arthritis (joint), TMD headache (muscle), other (neither). The diagnosis will be measured as one of four options: 1. joint; 2. muscle; 3. both; or 4. neither.

    Measured: Measured directly after the PT evaluation (Day 1)

  2. Diagnostic agreement

    Agreement data for each subject will be collected comparing two specialist diagnoses: dentist and physical therapist. Agreement about the diagnostic category will be recorded as a binary "yes/no" measure.

    Measured: Measured directly after the PT evaluation (Day 1)

  3. The Oral Health Impact Profile for TMD summary score

    The OHIP-TMD is a condition-specific quality-of-life scale with 22 items and a 0-4 scoring option for each item. A higher score means lower quality-of life. The summary score after 6 weeks will be compared to the baseline summary score, and a score decrease ≥6.9 units will be considered evidence of therapy success. The proportion of therapy success in each group will be used for non-inferiority comparison.

    Measured: 6 weeks after intervention onset

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted8 Apr 2022
  2. Study start17 Jun 2022
  3. Primary completion1 Jul 2024
  4. Study completion1 Jul 2024

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Cohort
Time perspective
Prospective
Enrolment
207 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT05318313
Sponsor's protocol ID
DENT-2022-30141
Status last verified
Jan 2026
First submitted
3 Mar 2022
Last updated
6 Jan 2026
Results posted
No
FDA-regulated drug
No
FDA-regulated device
No

Questions about this trial

What is this clinical trial studying?

An observational study of Temporomandibular Disorder and TMJ Disc Displacement With Reduction, run by University of Minnesota at 1 site in United States.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 7 inclusion and 13 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 6 Jan 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Specialist diagnosis (time frame: Measured directly after the PT evaluation (Day 1)). The study lists 3 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 6 Jan 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in